InMed Pharmaceuticals Inc Stock News
$2.10
2.78%
today
Nasdaq,
Oct 22, 05:07 pm CET
Index
Industry
InMed Pharmaceuticals Inc Stock News
Neutral
GlobeNewsWire
●
about one month ago
VANCOUVER, British Columbia, Sept. 16, 2025 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that Eric A. Adams, InMed's CEO, will present live at the Life Sciences Virtual Investor Forum hoste...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
